New Cancer Cure-Bio Co.,Ltd.
2 clinical trials · Sponsor
◉ Watch New Cancer Cure-Bio Co.,Ltd.
| Record | Firm | Date |
|---|---|---|
| The KN510713 Study in Combination With mFOLFIRINOX (NCT07114861) | New Cancer Cure-Bio Co.,Ltd. | 2025-12-16 |
| Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 (NCT06012708) | New Cancer Cure-Bio Co.,Ltd. | 2023-09-11 |
Track New Cancer Cure-Bio Co.,Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.